Cynthia J. Tsui
FDA investigator
Appears on 2 documents from 2024 to 2026, mostly at sites in California. Most often cites general responsibilities of sponsors (21 CFR 312.50).
- 2
- Documents on file
- 1.5
- Observations per 483
- 2024
- First seen
- 2026
- Most recent
What they cite most
From 3 observations- 21 CFR 312.50General responsibilities of sponsors1
- 21 CFR 312.53(c)(1)Selecting investigators and monitors1
- 21 CFR 314.80(c)(1)(i)Postmarketing reporting of adverse drug experiences1
Activity by year
2024: 1, 2026: 1
Where
California 2
Often inspects with
Is Cynthia J. Tsui coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2026-03-02 | 483 Vera Therapeutics, Inc. 2000 Sierra Point Pkwy STE 1200Mar 2, 2026 · Brisbane, California | Brisbane, California | 2 | |
| 2024-01-22 | 483 ASEGUA THERAPEUTICS LLCJan 22, 2024 · Foster City, California | Foster City, California | 1 |
About this profile
What does Cynthia J. Tsui inspect?
Cynthia J. Tsui appears on 2 documents on file covering 2 sites, mostly in California.
What do they cite most often?
21 CFR 312.50 (general responsibilities of sponsors), followed by 21 CFR 312.53(c)(1) and 21 CFR 314.80(c)(1)(i).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Cynthia J. Tsui is dated Mar 2, 2026.